MerLion Pharmaceuticals Pte. Ltd.
MerLion Pharmaceuticals Pte. Ltd., a prominent player in the biopharmaceutical industry, is headquartered in Singapore (SG) and operates extensively across Asia and Europe. Founded in 2006, the company has made significant strides in developing innovative therapeutics, particularly in the fields of infectious diseases and oncology. MerLion is renowned for its unique portfolio of products, including novel antibiotics and anti-cancer agents, which are distinguished by their targeted mechanisms of action and commitment to addressing unmet medical needs. With a strong focus on research and development, the company has achieved notable milestones, positioning itself as a leader in the fight against drug-resistant infections. Through its dedication to advancing healthcare solutions, MerLion Pharmaceuticals continues to enhance its market presence and contribute to global health initiatives.
DitchCarbon Score
How does MerLion Pharmaceuticals Pte. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MerLion Pharmaceuticals Pte. Ltd.'s score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MerLion Pharmaceuticals Pte. Ltd.'s reported carbon emissions
MerLion Pharmaceuticals Pte. Ltd., headquartered in Singapore (SG), currently does not have any publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges from the company, indicating a lack of formal commitments towards reducing their carbon footprint at this time. In the context of the pharmaceutical industry, where sustainability and climate action are increasingly important, MerLion Pharmaceuticals may need to consider establishing clear climate commitments and reduction initiatives to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MerLion Pharmaceuticals Pte. Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
